Pakistan Drug Safety Boost as DRAP Karachi Lab Wins WHO Prequalification
Pakistan drug safety has reached a key milestone with global recognition. The Central Drug Testing Laboratory in Karachi earned WHO prequalification. This step strengthens trust in medicine quality across the country.
The lab operates under the Drug Regulatory Authority of Pakistan. It now meets strict standards set by the World Health Organization. As a result, testing quality aligns with global benchmarks.
What WHO Recognition Means
WHO prequalification is a strict global validation system. It checks accuracy, quality, and technical reliability. Therefore, the approval builds strong confidence in local testing systems.
Medicines tested at the Central Drug Testing Laboratory now meet international standards. This ensures safer treatments for patients. In addition, doctors can rely more on prescribed medicines.
This recognition also supports better regulatory oversight. It helps detect substandard or counterfeit drugs faster. As a result, public health protection improves.
Impact on Healthcare and Exports
This milestone benefits both healthcare and the economy. Patients gain safer medicines, while doctors get better assurance. Moreover, regulators can enforce quality standards more effectively.
The achievement also boosts export potential. Pakistani pharmaceutical companies can now show stronger compliance. For example, global buyers may trust “Made in Pakistan” medicines more.
What Comes Next
Experts see this as a starting point, not the end. More labs need similar upgrades across Pakistan. However, maintaining standards will remain essential.
Continuous monitoring and investment will support long-term progress. Therefore, expanding WHO-level systems can strengthen the entire healthcare network. Pakistan drug safety now moves forward with renewed global confidence.
